BackAIkido Pharma Overview
AIkido Pharma Inc

AIkido Pharma Debt to Equity

AIkido Pharma (AIKI) has a debt-to-equity ratio of 0.71, below the Industrials sector average of 1.27.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

0.71

Debt to Equity

0.71

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

AIkido Pharma (AIKI) FAQ

As of the most recent data, AIKI shows a debt-to-equity ratio of 0.71. That is below the Industrials sector average of 1.27. Scroll down for historical charts and peer comparison views.

The Industrials sector average debt-to-equity ratio is about 1.27. AIkido Pharma is at 0.71, which is lower that average. That is roughly 43.8% below the sector mean. Use the comparison chart on this page to see how AIKI stacks up against individual peers as well.

Investors watch AIKI's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. AIkido Pharma's latest reading is 0.71. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has AIkido Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 0.71) with ownership activity and broader fundamentals.

The Industrials average debt-to-equity ratio is about 1.27, while AIKI is at 0.71. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.